Clinical Observation of 5-Fu/LV in Combination with Oxaliplatin or HCPT for Gasitric Cancer

Objective To compare the novel neoadjuvant approach of Oxaliplatin and 5-Fu/LV with the approach of HCPT and 5-Fu/LV for patients with advanced gastric carcinoma excised completely, and evaluate the 3-year livability and the adverse reaction. Methods 79 patients suffered gastric carcinoma excised accepted the treatment. Among those, 40 were treated by the approach of Oxaliplatin and 5-Fu/LV. 39 were treated by the approach of HCPT and 5-Fu/LV. The patients statistic characters were tested by χ 2. These two ...